US Patent Issued to The General Hospital on June 17 for "Digital analysis of blood samples to determine efficacy of cancer therapies for specific cancers" (Massachusetts Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,363, issued on June 17, was assigned to The General Hospital Corp. (Boston).

"Digital analysis of blood samples to determine efficacy of cancer therapies for specific cancers" was invented by Daniel Haber (Chestnut Hill, Mass.), Shyamala Maheswaran (Lexington, Mass.), Tanya Todorova (Malden, Mass.), Mark Kalinich (Cambridge, Mass.), David Tomoaki Miyamoto (Wellesley, Mass.) and Xin Hong (Malden, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to new assay methods for analysis of RNA, e.g., from circulating tumor cells (CTCs), tumor-specific exosomes, or tumor-specific cell-free RNA, in a subject's blood sample to determi...